| 1 |
Protasi F, Girolami B, Roccabianca S, Rossi D. Store-operated calcium entry: From physiology to tubular aggregate myopathy. Curr Opin Pharmacol 2023;68:102347. [PMID: 36608411 DOI: 10.1016/j.coph.2022.102347] [Reference Citation Analysis]
|
| 2 |
Brock S, Jackson DB, Soldatos TG, Hornischer K, Schäfer A, Diella F, Emmert MY, Hoerstrup SP. Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms. Front Mol Med 2023;2. [DOI: 10.3389/fmmed.2022.1035290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 3 |
Tsujikawa S, DeMeulenaere KE, Centeno MV, Ghazisaeidi S, Martin ME, Tapies MR, Maneshi MM, Yamashita M, Stauderman KA, Apkarian AV, Salter MW, Prakriya M. Regulation of neuropathic pain by microglial Orai1 channels. Sci Adv 2023;9:eade7002. [PMID: 36706180 DOI: 10.1126/sciadv.ade7002] [Reference Citation Analysis]
|
| 4 |
Goriounova AS, Gilmore RC, Wrennall JA, Tarran R. Super resolution microscopy analysis reveals increased Orai1 activity in asthma and cystic fibrosis lungs. J Cyst Fibros 2023;22:161-71. [PMID: 35961837 DOI: 10.1016/j.jcf.2022.07.003] [Reference Citation Analysis]
|
| 5 |
Chastain DB, Patel VS, Jefferson AM, Osae SP, Chastain JS, Henao-Martínez AF, Franco-Paredes C, Young HN. Distribution of age, sex, race, and ethnicity in COVID-19 clinical drug trials in the United States: A review. Contemp Clin Trials 2022;123:106997. [PMID: 36368481 DOI: 10.1016/j.cct.2022.106997] [Reference Citation Analysis]
|
| 6 |
Milenina L, Krutetskaya Z, Antonov V, Krutetskaya N, Badulina V, Simonyan A. NEUROLEPTICS ATTENUATE Ca2+ RESPONSES INDUCED BY GLUTOXIM AND MOLIXAN IN MACROPHAGES. Russian Journal of Biological Physics and Chemisrty 2022;7:127-136. [DOI: 10.29039/rusjbpc.2022.0494] [Reference Citation Analysis]
|
| 7 |
Sabourin J, Beauvais A, Luo R, Montani D, Benitah J, Masson B, Antigny F. The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology. Cells 2022;11:3282. [DOI: 10.3390/cells11203282] [Reference Citation Analysis]
|
| 8 |
Masson B, Le Ribeuz H, Sabourin J, Laubry L, Woodhouse E, Foster R, Ruchon Y, Dutheil M, Boët A, Ghigna MR, De Montpreville VT, Mercier O, Beech DJ, Benitah JP, Bailey MA, Humbert M, Montani D, Capuano V, Antigny F. Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension. Circ Res 2022;131:e102-19. [PMID: 36164973 DOI: 10.1161/CIRCRESAHA.122.321041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Cheng Q, Zhao G, Chen J, Jia Q, Fang Z. Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials. Medicine 2022;101:e30998. [DOI: 10.1097/md.0000000000030998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Tsujikawa S, Demeulenaere KE, Centeno MV, Ghazisaeidi S, Martin ME, Tapies MR, Maneshi MM, Yamashita M, Stauderman KA, Apkarian AV, Salter MW, Prakriya M. Regulation of neuropathic pain by microglial Orai1 channels.. [DOI: 10.1101/2022.09.02.506250] [Reference Citation Analysis]
|
| 11 |
Glauben R, Letizia M, Weidinger C. Targeting SOCE in Intestinal Epithelial Cells: A New Treatment Concept for Inflammatory Bowel Disease? Cell Mol Gastroenterol Hepatol 2022;14:243-4. [PMID: 35523355 DOI: 10.1016/j.jcmgh.2022.04.008] [Reference Citation Analysis]
|
| 12 |
Riva B, Pessolano E, Quaglia E, Cordero-sanchez C, Bhela IP, Topf A, Serafini M, Cox D, Harris E, Garibaldi M, Barresi R, Pirali T, Genazzani AA. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39. Cell Calcium 2022. [DOI: 10.1016/j.ceca.2022.102605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Joshy AS, Thomas C, Surendran S, Undela K. Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of Randomized Controlled Trials Published on COVID-19.. [DOI: 10.1101/2022.04.15.22273881] [Reference Citation Analysis]
|
| 14 |
Fenton C, Keam SJ. Emerging small molecule antivirals may fit neatly into COVID-19 treatment. Drugs Ther Perspect 2022;38:112-26. [PMID: 35250258 DOI: 10.1007/s40267-022-00897-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 15 |
Shawer H, Cheng CW, Bailey MA. Absence of association between host genetic mutations in the ORAI1 gene and COVID-19 fatality. PLoS ONE 2022;17:e0263303. [DOI: 10.1371/journal.pone.0263303] [Reference Citation Analysis]
|
| 16 |
Berlansky S, Sallinger M, Grabmayr H, Humer C, Bernhard A, Fahrner M, Frischauf I. Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies. Cells 2022;11. [PMID: 35053369 DOI: 10.3390/cells11020253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 17 |
Cheng Q, Zhao G, Chen J, Jia Q, Fang Z. Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: A network meta-analysis of randomized controlled trials. J Med Virol 2021. [PMID: 34882805 DOI: 10.1002/jmv.27512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Masson B, Montani D, Humbert M, Capuano V, Antigny F. Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension. Biomolecules 2021;11:1781. [PMID: 34944425 DOI: 10.3390/biom11121781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Honarmand K, Penn J, Agarwal A, Siemieniuk R, Brignardello-Petersen R, Bartoszko JJ, Zeraatkar D, Agoritsas T, Burns K, Fernando SM, Foroutan F, Ge L, Lamontagne F, Jimenez-Mora MA, Murthy S, Yepes-Nuñez JJ, Vandvik PO, Ye Z, Rochwerg B. Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality. J Clin Epidemiol 2021;139:68-79. [PMID: 34274489 DOI: 10.1016/j.jclinepi.2021.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 20 |
Wang D, Chen L, Wang L, Hua F, Li J, Li Y, Zhang Y, Fan H, Li W, Clarke M. Abstracts for reports of randomised trials of COVID-19 interventions had low quality and high spin. J Clin Epidemiol 2021;139:107-20. [PMID: 34224834 DOI: 10.1016/j.jclinepi.2021.06.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 21 |
Cheng Q, Chen J, Jia Q, Fang Z, Zhao G. Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials. Aging (Albany NY) 2021;13:21866-902. [PMID: 34531332 DOI: 10.18632/aging.203522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 22 |
Letizia M, Kaufmann U, Wang Y, Gerbeth L, Sand A, Brunkhorst M, Ziegler JF, Böttcher C, Schlickeiser S, Fernández-zapata C, Stauderman K, Kunkel D, Siegmund B, Feske S, Weidinger C, IBDome researchers. Store-Operated Calcium Entry Controls Innate and Adaptive Immune Cell Function in Inflammatory Bowel Disease.. [DOI: 10.1101/2021.09.11.21263401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Kountz TS, Jairaman A, Kountz CD, Stauderman KA, Schleimer RP, Prakriya M. Differential Regulation of ATP- and UTP-Evoked Prostaglandin E2 and IL-6 Production from Human Airway Epithelial Cells. J Immunol 2021;207:1275-87. [PMID: 34389624 DOI: 10.4049/jimmunol.2100127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 24 |
Bokharee N, Khan YH, Khokhar A, Mallhi TH, Alotaibi NH, Rasheed M. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert Rev Anti Infect Ther 2021;:1-26. [PMID: 33719819 DOI: 10.1080/14787210.2021.1902805] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Zhao MZ, Zhao C, Tu SS, Wei XX, Shang HC. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. J Integr Med 2021;19:317-26. [PMID: 33789839 DOI: 10.1016/j.joim.2021.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 26 |
Petersen OH, Gerasimenko JV, Gerasimenko OV, Gryshchenko O, Peng S. The roles of calcium and ATP in the physiology and pathology of the exocrine pancreas. Physiol Rev 2021;101:1691-744. [PMID: 33949875 DOI: 10.1152/physrev.00003.2021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 27 |
Shawer H, Norman K, Cheng CW, Foster R, Beech DJ, Bailey MA. ORAI1 Ca2+ Channel as a Therapeutic Target in Pathological Vascular Remodelling. Front Cell Dev Biol 2021;9:653812. [PMID: 33937254 DOI: 10.3389/fcell.2021.653812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Bruen C, Miller J, Wilburn J, Mackey C, Bollen TL, Stauderman K, Hebbar S. Auxora for the Treatment of Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome: Clinical Development of a Calcium Release-Activated Calcium Channel Inhibitor. Pancreas 2021;50:537-43. [PMID: 33939666 DOI: 10.1097/MPA.0000000000001793] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 29 |
Welte T, Ambrose LJ, Sibbring GC, Sheikh S, Müllerová H, Sabir I. Current evidence for COVID-19 therapies: a systematic literature review. Eur Respir Rev 2021;30. [PMID: 33731328 DOI: 10.1183/16000617.0384-2020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 30 |
Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, Holgersson J, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Bu F, Klingenberg S, Gluud C, Jakobsen JC. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). PLoS One 2021;16:e0248132. [PMID: 33705495 DOI: 10.1371/journal.pone.0248132] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 31 |
Rabow M, Wang C, Zhang S, Tahir PM, Small EJ, Borno HT. Examining reporting and representation of patients with cancer in COVID-19 clinical trials. Cancer Rep (Hoboken) 2021;4:e1355. [PMID: 33621447 DOI: 10.1002/cnr2.1355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 32 |
Diallo A, Carlos-Bolumbu M, Traoré M, Diallo MH, Jedrecy C. An updated systematic review and network meta-analysis of 25 randomized trials assessing the efficacy and safety of treatments in COVID-19 disease. J Public Health Res 2021;10:1945. [PMID: 33634043 DOI: 10.4081/jphr.2021.1945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J, Koyanagi A, Hong SH, Dragioti E, Radua J, Smith L, Oh H, Ghayda RA, Kronbichler A, Effenberger M, Kresse D, Denicolò S, Kang W, Jacob L, Shin H, Shin JI. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. Theranostics 2021;11:1207-31. [PMID: 33391531 DOI: 10.7150/thno.48342] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 34 |
Zhang C, Jin H, Wen Y, Yin G. A Systematic Review and Network Meta-Analysis for COVID-19 Treatments.. [DOI: 10.1101/2020.12.21.20248621] [Reference Citation Analysis]
|
| 35 |
Welte T, Ambrose LJ, Sibbring GC, Sheikh S, Müllerová H, Sabir I. Current evidence for COVID-19 therapies: a systematic literature review.. [DOI: 10.1101/2020.12.18.20248452] [Reference Citation Analysis]
|
| 36 |
Tiffner A, Derler I. Molecular Choreography and Structure of Ca2+ Release-Activated Ca2+ (CRAC) and KCa2+ Channels and Their Relevance in Disease with Special Focus on Cancer. Membranes (Basel) 2020;10:E425. [PMID: 33333945 DOI: 10.3390/membranes10120425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 37 |
Honarmand K, Penn J, Agarwal A, Siemieniuk R, Brignardello-petersen R, Bartoszko JJ, Zeraatkar D, Agoritsas T, Burns K, Fernando SM, Foroutan F, Ge L, Lamontagne F, Jimenez-mora MA, Murthy S, Yepes Nuñez JJ, Vandvik PO, Ye Z, Rochwerg B. Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining methodological quality.. [DOI: 10.1101/2020.11.29.20237875] [Reference Citation Analysis]
|
| 38 |
Juul S, Nielsen EE, Feinberg J, Siddiqui F, Jørgensen CK, Barot E, Holgersson J, Nielsen N, Bentzer P, Veroniki AA, Thabane L, Bu F, Klingenberg S, Gluud C, Jakobsen JC. Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).. [DOI: 10.1101/2020.11.22.20236448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 39 |
Luo R, Gomez AM, Benitah JP, Sabourin J. Targeting Orai1-Mediated Store-Operated Ca2+ Entry in Heart Failure. Front Cell Dev Biol 2020;8:586109. [PMID: 33117812 DOI: 10.3389/fcell.2020.586109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
